Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1381908
                    [Title] => ‘Chemobrain’ may start before chemotherapy
                    [Summary] => 
The muddled thinking that sometimes affects breast cancer patients is manifested by decreased activity in a brain region that plays a key role in working memory, according to results of a functional imaging study.

                    [DatePublished] => 2014-10-19 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1252258
                    [Title] => FDA approves Roche drug for chronic leukemia based on research that it slows disease
                    [Summary] => 
The Food and Drug Administration on Friday approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow.

                    [DatePublished] => 2013-11-02 05:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img534.imageshack.us/img534/3584/4nve.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 911748
                    [Title] => Hair, care, share: Hair loss adds to cancer trauma
                    [Summary] => 
The gravity of her son’s illness struck Maria Roleta Miranda hard when she saw strands of hair on the boy’s pillow one morning last week.

                    [DatePublished] => 2013-02-22 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => News Commentary
                    [SectionUrl] => news-commentary
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 768485
                    [Title] => My head is now covered with hair
                    [Summary] => 
After months of chemotherapy and weeks of radiation, I am happy to share that the most critical and challenging part of my treatment is over.
                    [DatePublished] => 2012-01-18 00:00:00
                    [ColumnID] => 134670
                    [Focus] => 0
                    [AuthorID] => 1767481
                    [AuthorName] => Tetta Matera
                    [SectionName] => Fashion and Beauty
                    [SectionUrl] => fashion-and-beauty
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 743585
                    [Title] => Roche launches  drug for advanced  ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-03 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 742896
                    [Title] => First-line treatment for advanced ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 740509
                    [Title] => Breast cancer:  Progress & promise in 2011
                    [Summary] => 
The field of breast cancer has been a model for innovation and discovery.
                    [DatePublished] => 2011-10-25 00:00:00
                    [ColumnID] => 133436
                    [Focus] => 0
                    [AuthorID] => 1778504
                    [AuthorName] => Tyrone M. Reyes M.D.
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img714.imageshack.us/img714/6105/lif1thumba.jpg
                )

            [7] => Array
                (
                    [ArticleID] => 712918
                    [Title] => Chavez prepares for second round of chemotherapy
                    [Summary] => 
 Venezuelan President Hugo Chavez said Wednesday that he had well prepared himself both physically and spiritually for a second phase of chemotherapy to treat his cancer that would begin in the upcoming hours.
                    [DatePublished] => 2011-08-04 11:05:56
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 696213
                    [Title] => Roche drug halves risk of disease worsening in women with recurrent ovarian cancer
                    [Summary] => 
Roche recently announced the results from OCEANS, a phase III study evaluating bevacizumab in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of bevacizumab alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
                    [DatePublished] => 2011-06-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 678152
                    [Title] => Roche bares positive results of breast cancer drug
                    [Summary] => 
BASEL, Switzerland — Roche has announced the topline results of its first randomized trial of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer.
                    [DatePublished] => 2011-04-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

CHEMOTHERAPY

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1381908
                    [Title] => ‘Chemobrain’ may start before chemotherapy
                    [Summary] => 
The muddled thinking that sometimes affects breast cancer patients is manifested by decreased activity in a brain region that plays a key role in working memory, according to results of a functional imaging study.

                    [DatePublished] => 2014-10-19 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 1252258
                    [Title] => FDA approves Roche drug for chronic leukemia based on research that it slows disease
                    [Summary] => 
The Food and Drug Administration on Friday approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow.

                    [DatePublished] => 2013-11-02 05:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img534.imageshack.us/img534/3584/4nve.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 911748
                    [Title] => Hair, care, share: Hair loss adds to cancer trauma
                    [Summary] => 
The gravity of her son’s illness struck Maria Roleta Miranda hard when she saw strands of hair on the boy’s pillow one morning last week.

                    [DatePublished] => 2013-02-22 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => News Commentary
                    [SectionUrl] => news-commentary
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 768485
                    [Title] => My head is now covered with hair
                    [Summary] => 
After months of chemotherapy and weeks of radiation, I am happy to share that the most critical and challenging part of my treatment is over.
                    [DatePublished] => 2012-01-18 00:00:00
                    [ColumnID] => 134670
                    [Focus] => 0
                    [AuthorID] => 1767481
                    [AuthorName] => Tetta Matera
                    [SectionName] => Fashion and Beauty
                    [SectionUrl] => fashion-and-beauty
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 743585
                    [Title] => Roche launches  drug for advanced  ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-03 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 742896
                    [Title] => First-line treatment for advanced ovarian cancer
                    [Summary] => 
Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
                    [DatePublished] => 2011-11-01 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 740509
                    [Title] => Breast cancer:  Progress & promise in 2011
                    [Summary] => 
The field of breast cancer has been a model for innovation and discovery.
                    [DatePublished] => 2011-10-25 00:00:00
                    [ColumnID] => 133436
                    [Focus] => 0
                    [AuthorID] => 1778504
                    [AuthorName] => Tyrone M. Reyes M.D.
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img714.imageshack.us/img714/6105/lif1thumba.jpg
                )

            [7] => Array
                (
                    [ArticleID] => 712918
                    [Title] => Chavez prepares for second round of chemotherapy
                    [Summary] => 
 Venezuelan President Hugo Chavez said Wednesday that he had well prepared himself both physically and spiritually for a second phase of chemotherapy to treat his cancer that would begin in the upcoming hours.
                    [DatePublished] => 2011-08-04 11:05:56
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 696213
                    [Title] => Roche drug halves risk of disease worsening in women with recurrent ovarian cancer
                    [Summary] => 
Roche recently announced the results from OCEANS, a phase III study evaluating bevacizumab in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of bevacizumab alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
                    [DatePublished] => 2011-06-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 678152
                    [Title] => Roche bares positive results of breast cancer drug
                    [Summary] => 
BASEL, Switzerland — Roche has announced the topline results of its first randomized trial of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer.
                    [DatePublished] => 2011-04-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

‘Chemobrain’ may start before chemotherapy

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | October 19, 2014 - 12:00am

The muddled thinking that sometimes affects breast cancer patients is manifested by decreased activity in a brain region that plays a key role in working memory, according to results of a functional imaging stu...

Opinion

FDA approves Roche drug for chronic leukemia based on research that it slows disease

November 2, 2013 - 5:00am

The Food and Drug Administration on Friday approved a new drug from Roche to help treat patients with a type of cancer of...

Health And Family

Hair, care, share: Hair loss adds to cancer trauma

By Sheila Crisostomo | February 22, 2013 - 12:00am

The gravity of her son’s illness struck Maria Roleta Miranda hard when she saw strands of hair on the boy’s pillow one morning last week.

News Commentary

My head is now covered with hair

By Tetta Matera | January 18, 2012 - 12:00am

After months of chemotherapy and weeks of radiation, I am happy to share that the most critical and challenging part of my treatment is over.

Fashion and Beauty

Roche launches drug for advanced ovarian cancer

November 3, 2011 - 12:00am

Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.

Science and Environment

First-line treatment for advanced ovarian cancer

November 1, 2011 - 12:00am

Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.

Health And Family

Breast cancer: Progress & promise in 2011

By Tyrone M. Reyes M.D. | October 25, 2011 - 12:00am

The field of breast cancer has been a model for innovation and discovery.

Health And Family

Chavez prepares for second round of chemotherapy

August 4, 2011 - 11:05am

 Venezuelan President Hugo Chavez said Wednesday that he had well prepared himself both physically and spiritually for a second phase of chemotherapy to treat his cancer that would begin in the upcoming ho...

Roche drug halves risk of disease worsening in women with recurrent ovarian cancer

June 16, 2011 - 12:00am

Roche recently announced the results from OCEANS, a phase III study evaluating bevacizumab in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of bevacizumab alone in women...

Science and Environment

Roche bares positive results of breast cancer drug

April 21, 2011 - 12:00am

BASEL, Switzerland — Roche has announced the topline results of its first randomized trial of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer.

Science and Environment